Skip to content
TESCT — Trans European Stem Cell Therapy Society
Delegates at a TESCT work meeting

7th work meeting

Champéry, Switzerland

In the Valais Alps: gene editing in Parkinson's and heart disease, European health systems and co-morbidity, and the society's own future establishment.

Dates
16–18 June 2017
Venue
Hotel National Resort & Spa, Champéry, Valais, Switzerland
Convened by
Dr. Marco Traub

Programme

What was discussed

  1. 01

    European Innovation Partnership on Active and Healthy Ageing

  2. 02

    Gene editing in Parkinson's and heart disease

  3. 03

    European health care systems and co-morbidity

  4. 04

    Paradigm change: shifting from patient centricity to society, and pharma as a holistic view

  5. 05

    TESCT Society: future establishment

Recalling Prof. Dame Julia Polak, TESCT meeting 2006

“Regenerative medicine is an emerging field that approaches the repair or replacement of tissues and organs by incorporating the use of cells, genes or other biological building blocks along with bioengineered materials and technologies. Advances in stem cell biology, including the isolation and characterisation of embryonic and post-natal somatic stem cells, have made the prospect of tissue repair a realistic one.”

Speakers

Who spoke

  • Dr. Mary Baker, MBE

    Management Board of the European Medicines Agency (EMEA); Chair of the Working Group on Parkinson's Disease

  • Marco Perduca

    Former Senator in Italy; Associazione Luca Coscioni

  • Prof. Tomas J. Ekström

    Department of Clinical Neuroscience, Karolinska Institutet, Sweden

  • Prof. Miomir Knezevic

    National Institute of Biology, University of Ljubljana, Slovenia

  • Dr. Marisa Jaconi

    University of Geneva, Switzerland

  • Dr. Colin Natali

    The Royal London Hospital, Whitechapel, London

  • Dr. Jeya Prakash

    Age Management Consultant, Harley Street, London

  • Dr. Srividya Seshadri

    The Centre for Reproductive & Genetic Health, London

  • Dr. Alagappan Sivaram

    Consultant Orthopaedic Spinal Surgeon, London

  • Dr. Marco Traub

    Project Coordinator and CEO, TESCT, Berne and London